Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruption - ScienceDirect
Natalizumab treatment of multiple sclerosis: new insights | Immunotherapy
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR) - Sabol - 2017 - Cancer Medicine - Wiley Online Library
Simplified overview of postulated mechanism of action of standard... | Download Scientific Diagram
Science Source Stock Photo - Natalizumab Mechanism of Action, Illustration
Mechanism of action of natalizumab. | Download Scientific Diagram
Treating Multiple Sclerosis With Monoclonal Antibodies
Figure 1 | The Role of Alpha-4 Integrin in the Aetiology of Multiple Sclerosis | SpringerLink
Figure 3 from Predictors of Response to Multiple Sclerosis Therapeutics in Individual Patients | Semantic Scholar
Spanish consensus on the use of natalizumab (Tysabri®) – 2011 | Neurología (English Edition)
Identification and development of new therapeutics for multiple sclerosis: Trends in Pharmacological Sciences
Aaron Boster MD on Twitter: "Click to learn how Tysabri (Natalizumab) works in #MS: https://t.co/TUYQqJTzQo #MultipleSclerosis #Tysabri https://t.co/WC7xvLO3EK" / Twitter
Natalizumab (Tysabri) | American Journal of Neuroradiology
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
VLA‐4 blockade by natalizumab inhibits sickle reticulocyte and leucocyte adhesion during simulated blood flow - White - 2016 - British Journal of Haematology - Wiley Online Library
Natalizumab for Multiple Sclerosis | NEJM
Natalizumab (Tysabri) | American Journal of Neuroradiology
Natalizumab - Wikipedia
Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab | Nature Reviews Drug Discovery
Biomedicines | Free Full-Text | Monoclonal Antibodies in Multiple Sclerosis: Present and Future | HTML
Mechanism of action of natalizumab. | Download Scientific Diagram
Natalizumab (Tysabri). - Abstract - Europe PMC
Natalizumab blocks lymphocyte homing in MS. (A) 4 integrin binds to... | Download Scientific Diagram
Brain Sciences | Free Full-Text | Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab
The use of immune modulating drugs for the treatment of multiple sclerosis | Neurosciences Journal
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring - The Lancet Neurology
